| 17alpha-ethynylestradiol | affects expression | ISO | RGD:731691 | 6480464 | Ethinyl Estradiol affects the expression of CX3CL1 mRNA | CTD | PMID:17555576 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731691 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA] | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:620458 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CX3CL1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CX3CL1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731691 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CX3CL1 mRNA | CTD | PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731691 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CX3CL1 mRNA] | CTD | PMID:15667827 |
| 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | EXP | | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of CX3CL1 mRNA | CTD | PMID:17547211 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731691 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of CX3CL1 mRNA | CTD | PMID:15973123 |
| 2-acetamidofluorene | increases expression | ISO | RGD:620458 | 6480464 | 2-Acetylaminofluorene results in increased expression of CX3CL1 mRNA | CTD | PMID:17187413 |
| 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CX3CL1 mRNA | CTD | PMID:21179406 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:620458 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CX3CL1 mRNA | CTD | PMID:19692669 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:731691 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA; more ... | CTD | PMID:16054899 |
| 3-methylcholanthrene | increases expression | ISO | RGD:731691 | 6480464 | Methylcholanthrene results in increased expression of CX3CL1 mRNA | CTD | PMID:20713471 |
| 8-bromo-3',5'-cyclic AMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CX3CL1 mRNA | CTD | PMID:22079614 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 protein]; more ... | CTD | PMID:19493461 |
| acetylsalicylic acid | decreases expression | ISO | RGD:731691 | 6480464 | Aspirin results in decreased expression of CX3CL1 protein; more ... | CTD | PMID:19997773 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of CX3CL1 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:620458 | 6480464 | Tretinoin results in decreased expression of CX3CL1 mRNA | CTD | PMID:20488242 |
| ammonium chloride | affects expression | ISO | RGD:620458 | 6480464 | Ammonium Chloride affects the expression of CX3CL1 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | multiple interactions | ISO | RGD:731691 | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of CX3CL1 mRNA] | CTD | PMID:18929588 |
| arsenite(3-) | decreases expression | ISO | RGD:731691 | 6480464 | arsenite results in decreased expression of CX3CL1 mRNA | CTD | PMID:18929588 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731691 | 6480464 | Benzo(a)pyrene results in decreased expression of CX3CL1 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases expression | ISO | RGD:731691 | 6480464 | Benzo(a)pyrene results in increased expression of CX3CL1 mRNA | CTD | PMID:22228805 |
| capsaicin | affects expression | ISO | RGD:620458 | 6480464 | Capsaicin affects the expression of CX3CL1 protein | CTD | PMID:22150557 |
| capsaicin | multiple interactions | ISO | RGD:620458 | 6480464 | Naproxen inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]; more ... | CTD | PMID:22150557 |
| chloroprene | decreases expression | ISO | RGD:620458 | 6480464 | Chloroprene results in decreased expression of CX3CL1 mRNA | CTD | PMID:23125180 |
| chromium atom | decreases expression | EXP | | 6480464 | Chromium results in decreased expression of CX3CL1 mRNA | CTD | PMID:17547211 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:731691 | 6480464 | Ciguatoxins affects the expression of CX3CL1 mRNA | CTD | PMID:18353800 |
| clofibrate | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; more ... | CTD | PMID:19132243 |
| cocaine | increases expression | ISO | RGD:620458 | 6480464 | Cocaine results in increased expression of CX3CL1 mRNA | CTD | PMID:16076954 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CX3CL1 mRNA | CTD | PMID:19549813 |
| cyclophosphamide | increases expression | ISO | RGD:620458 | 6480464 | Cyclophosphamide results in increased expression of CX3CL1 protein | CTD | PMID:16651033 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CX3CL1 mRNA | CTD | PMID:20106945 |
| D-glucose | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; more ... | CTD | PMID:19132243 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CX3CL1 mRNA; more ... | CTD | PMID:19132243 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:731691 | 6480464 | Tetrahydrocannabinol results in decreased expression of CX3CL1 mRNA | CTD | PMID:12237329 |
| dexamethasone | multiple interactions | ISO | RGD:731691 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA; more ... | CTD | PMID:16054899 |
| dexamethasone | increases expression | ISO | RGD:731691 | 6480464 | Dexamethasone results in increased expression of CX3CL1 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of CX3CL1 mRNA | CTD | PMID:17547211 |
| dibutyl phthalate | increases expression | ISO | RGD:620458 | 6480464 | Dibutyl Phthalate results in increased expression of CX3CL1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:731691 | 6480464 | Dibutyl Phthalate results in increased expression of CX3CL1 mRNA | CTD | PMID:21266533 |
| dioxygen | increases response to substance | EXP | | 6480464 | Oxygen deficiency results in increased susceptibility to CX3CL1 protein | CTD | PMID:17476338 |
| ethanol | affects expression | ISO | RGD:620458 | 6480464 | Ethanol affects the expression of CX3CL1 mRNA | CTD | PMID:11772933 |
| fenofibrate | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; more ... | CTD | PMID:19132243 |
| glucose | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; more ... | CTD | PMID:19132243 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CX3CL1 mRNA; more ... | CTD | PMID:19132243 |
| hydrogen peroxide | multiple interactions | ISO | RGD:620458 | 6480464 | CX3CL1 inhibits the reaction [Vehicle Emissions results in increased abundance of Hydrogen Peroxide] | CTD | PMID:21561831 |
| ibuprofen | affects expression | EXP | | 6480464 | Ibuprofen affects the expression of CX3CL1 mRNA | CTD | PMID:17070997 |
| ketamine | increases expression | ISO | RGD:620458 | 6480464 | Ketamine results in increased expression of CX3CL1 mRNA | CTD | PMID:20080153 |
| lead diacetate | increases secretion | ISO | RGD:620458 | 6480464 | lead acetate results in increased secretion of CX3CL1 protein | CTD | PMID:17047031 |
| methadone | increases secretion | ISO | RGD:620458 | 6480464 | Methadone results in increased secretion of CX3CL1 protein | CTD | PMID:20178837 |
| mifepristone | increases expression | EXP | | 6480464 | Mifepristone results in increased expression of CX3CL1 mRNA | CTD | PMID:17584828 |
| morphine | affects response to substance | ISO | RGD:620458 | 6480464 | CX3CL1 protein affects the susceptibility to Morphine | CTD | PMID:15317861 |
| morphine | increases secretion | ISO | RGD:620458 | 6480464 | Morphine results in increased secretion of CX3CL1 protein | CTD | PMID:20178837 |
| mycophenolic acid | increases expression | ISO | RGD:731691 | 6480464 | Mycophenolic Acid results in increased expression of CX3CL1 mRNA | CTD | PMID:19818335 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:620458 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CX3CL1 mRNA | CTD | PMID:18164116 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of CX3CL1 mRNA | CTD | PMID:17547211 |
| naproxen | multiple interactions | ISO | RGD:620458 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]; more ... | CTD | PMID:22150557 |
| nickel atom | affects expression | EXP | | 6480464 | Nickel affects the expression of CX3CL1 mRNA | CTD | PMID:14575637 |
| nickel atom | multiple interactions | EXP | | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of CX3CL1 mRNA] | CTD | PMID:14575637 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of CX3CL1 mRNA | CTD | PMID:17312168 |
| ozone | decreases expression | ISO | RGD:620458 | 6480464 | Ozone results in decreased expression of CX3CL1 mRNA | CTD | PMID:16716893 |
| p-cresol | multiple interactions | EXP | | 6480464 | 4-cresol inhibits the reaction [IL1B protein results in increased expression of CX3CL1 protein] | CTD | PMID:16954166 |
| paracetamol | affects expression | ISO | RGD:731691 | 6480464 | Acetaminophen affects the expression of CX3CL1 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:731691 | 6480464 | [MST1R protein mutant form co-treated with Acetaminophen] results in increased expression of CX3CL1 mRNA | CTD | PMID:22575169 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CX3CL1 mRNA | CTD | PMID:19159669 |
| phenytoin | increases expression | ISO | RGD:620458 | 6480464 | Phenytoin results in increased expression of CX3CL1 mRNA | CTD | PMID:20345932 |
| phorbol 13-acetate 12-myristate | decreases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of CX3CL1 mRNA | CTD | PMID:19850645 |
| potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of CX3CL1 mRNA | CTD | PMID:17547211 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CX3CL1 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein]; more ... | CTD | PMID:16614140 |
| resveratrol | multiple interactions | ISO | RGD:620458 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein] | CTD | PMID:16614140 |
| rosiglitazone | multiple interactions | ISO | RGD:731691 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA] | CTD | PMID:16054899 |
| rosiglitazone | affects localization | EXP | | 6480464 | rosiglitazone affects the localization of CX3CL1 protein | CTD | PMID:19850645 |
| sterigmatocystin | increases expression | ISO | RGD:731691 | 6480464 | Sterigmatocystin results in increased expression of CX3CL1 mRNA | CTD | PMID:19818335 |
| sumatriptan | multiple interactions | ISO | RGD:620458 | 6480464 | Sumatriptan inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]; more ... | CTD | PMID:22150557 |
| tamoxifen | affects expression | ISO | RGD:731691 | 6480464 | Tamoxifen affects the expression of CX3CL1 mRNA | CTD | PMID:17555576 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein]; more ... | CTD | PMID:16614140 |
| trans-resveratrol | multiple interactions | ISO | RGD:620458 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein] | CTD | PMID:16614140 |
| trichostatin A | multiple interactions | EXP | | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of CX3CL1 mRNA] | CTD | PMID:14575637 |
| valproic acid | decreases expression | ISO | RGD:731691 | 6480464 | Valproic Acid results in decreased expression of CX3CL1 mRNA | CTD | PMID:21427059 |
| valproic acid | increases expression | ISO | RGD:731691 | 6480464 | Valproic Acid results in increased expression of CX3CL1 mRNA | CTD | PMID:21427059 |
| vancomycin | decreases expression | ISO | RGD:731691 | 6480464 | Vancomycin results in decreased expression of CX3CL1 mRNA | CTD | PMID:18930951 |